EXOME

all the information, none of the junk | biotech • healthcare • life sciences

iWalk Steps Up with $15M More, Report Says

Cambridge, MA-based iWalk, the developer of an advanced prosthetic ankle and foot, has raised $15 million in its third round of financing, according to a report by Scott Kirsner of the Boston Globe. Boston-area venture firms Sigma Partners and General Catalyst participated in the round, as well as New York-based WFD Ventures, the report says. iWalk was founded in 2006 by MIT Media Lab professor Hugh Herr, and is led by CEO Tim McCarthy.

By posting a comment, you agree to our terms and conditions.

  • Steve

    Its hard to figure out what investor Sigma Partners, General Catalyst Partners and New York-based WFD Ventures LLC as well as Sigma’s Paul Flanagan see in iwalk. The company has been through 4 round of funding since it begain and 3 teams of engineers without delivering a production product. In fact one should wounder why the founder Hugh Herr still walks on an old school Carbon. I’m glad its not my money being invested.